1,441
Participants
Start Date
February 28, 2020
Primary Completion Date
August 6, 2024
Study Completion Date
September 30, 2024
TriVerity
Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection and sputum/ BAL sample collection
University of Pittsburgh, Pittsburgh
Geisinger Health, Danville
Medstar Health Research Institute, Washington D.C.
Johns Hopkins Hospital, Baltimore
Medical University of South Carolina, Charleston
Emory University, Atlanta
University of Florida (UF) - Jacksonville, Jacksonville
University of South Alabama, Mobile
Vanderbilt University Medical Center, Nashville
University of Kentucky, Lexington
Cleveland Clinic, Cleveland
Henry Ford Hospital, Detroit
University of Iowa, Iowa City
Medical College of Wisconsin, Milwaukee
Essentia Institute of Rural Health, Duluth
Mayo Clinic, Rochester
Washington University, St Louis
Oklahoma University Health, Oklahoma City
Baylor College of Medicine, Houston
Texas Tech University Health Sciences Center - El Paso, El Paso
University of Southern California, Los Angeles
University of California Davis Medical Center, Sacramento
Beth Israel Deaconess Medical Center, Boston
Baystate Medical Center, Springfield
Hackensack Meridian Health, Montclair
ATTIKON University Hospital, Athens
Lead Sponsor
Inflammatix
INDUSTRY